mCig Inc (OTCMKTS:MCIG) is one name that has left many investors disappointed. mCig was one of the original pot stocks that took off in 2014, only to crash and burn soon after leaving many investors with large losses. However, the company does have a lot of promise as vaporizers and the marijuana industry hold a lot of promise. But the past is the past and it’s time for investors to look forward and look at mCig objectively.
2016 is looking a lot better for mCig and pot stocks in general. Roughly 14 states could legalize marijuana this year, adult-use cannabis or possibly both, either at the ballot box or through state legislatures. While it’s doubtful all those states will be successful, there’s a good chance at least a handful will legalize in 2016. No other single year has offered such incredible promise in terms of the sheer volume of states that could legalize, thanks to other pioneering marijuana markets and growing support for cannabis in general.
mCig is positioned to benefit as a leading provider of advanced technologies and solutions to the global cannabis industry. mCig manufactures and markets best-selling portable and home vaporizers, extraction related equipment, CBD Rich Hemp Oil-derived products, and related nutraceuticals based on natural compounds found in Cannabis and Hemp plants. The company owns the mCig and Vapolution brands, and has a 47% stake in VitaCig (VTCQ), makers of the VitaStik, a disposable vitamin vaporizer.
Helping to drive sales is new products. mCig just unveiled its own branded CBD Vape pen and e-liquid that were developed in house. The new product, Kavva Vape, is an e-liquid that combines the healing powers of CBD hemp oil and Kava extract. Kava is used effectively to reduce anxiety, depression, and insomnia and promotes clear thinking, calmness, relaxed muscles, and a sense of well-being. Kavva Vape is available to order now in prefilled 1 ml tanks and comes in two flavors: Mint and Cool Citrus. Kavva Vape will be priced at $24.95 for a 1ml tank or $34.95 in combination with the new mCig CBD Vape pen.
mCig also just began to distribute another new product, Naturally Flavored High Grade CBD E-Juice, developed by Vitacig Inc. (OTCMKTS:VTCQ). The two vape oils or e-juices contain a perfected blend of CBD-rich hemp oil and natural flavorings. These new products and other mCig branded accessories are sold online or through affiliate websites and select brick and mortar locations.
VitaCig is also contributing after it just executed a new royalty and distribution agreement with its European partner. VitaCig U.S., and EU Vitastik Partner reached an agreement that will entitle VitaCig U.S., to royalty payments of up to 25% of all product sales. This agreement includes territories and partners throughout Europe, including UK, Austria, Switzerland, Spain, Italy, covering a population of 745 million people. According to this agreement, all product orders from Vitastik EU and their partners will go through a special EU VitaCig account. The term of this agreement runs effective January 1st 2016 – December 21st 2019. In addition to royalty payments, Vitastik EU will also take an active role in supporting the VitaCig product line relaunch, expected by March 1st, for the U.S. market.
Vitastik EU will also distribute VitaCig and mCig’s line of CBD products in Europe. The CBD industry in Europe is seeing tremendous growth as consumers and media reports continue to highlight CBD’s medical potential. Both parties anticipate, the initial product order, to be no less than $200k.
mCig is also one of the few pot stocks actually producing revenues. In the most recent quarter, revenues increased 1200% to $885,556 for the three months ended October 31, 2015 compared to $73,814 for the three months ended October 31, 2014.
Get the latest updates on MCIG by signing up to Insider Financial today
We Have A Monster Pick Coming Soon!
Don’t Miss Out!
Sign Up Below!
mCig has disappointed many shareholders in the past. However, we think the company is turning a corner and we could see some significant revenue growth on the back of new products and its new European distribution agreement. While we probably won’t see the highs we saw in 2014, mCig could easily touch $.10 at some point this year. We think the worst is behind mCig and better days are ahead for the company and its shareholders. Get the latest updates on MCIG by signing up in the box below. We will update our subscribers as soon as we know more on MCIG as we move forward in 2016.
Disclosure: We have no position in MCIG either long or short. We have not been compensated for this article.